| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/28/1998 | US5744347 Excising; detaching from membrane; collecting cells displaying a particular phenotype capable of giving rise to blood cells |
| 04/28/1998 | US5744329 DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin |
| 04/28/1998 | CA2057926C Chemical products |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016525A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/23/1998 | WO1998016523A2 Selective factor xa inhibitors |
| 04/23/1998 | WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 04/23/1998 | WO1998016235A1 Peripheral blood stem cell-increasing agents containing glycosides |
| 04/23/1998 | WO1998016204A1 Process for the manufacture of a pulverous preparation |
| 04/23/1998 | WO1998004686A3 Pro-protein converting enzyme |
| 04/23/1998 | CA2268281A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268264A1 Selective factor xa inhibitors |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2267110A1 Fanconi gene i |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837071A1 Tripeptide antithrombotic agents |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836615A1 New thrombin inhibitors, their preparation and use |
| 04/22/1998 | EP0836610A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 04/22/1998 | EP0836445A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/22/1998 | EP0627913B1 Facilitated oxygen delivery in conjunction with hemodilution |
| 04/22/1998 | EP0429480B1 Natriuretic hormone |
| 04/21/1998 | US5741804 Substituted benzimazoles which inhibit platelet aggrecation |
| 04/21/1998 | US5741781 Mercaptoalkanoyldipeptide compounds |
| 04/21/1998 | US5741779 Slowing clot formation in blood by administering bactericidal/permeability-increasing protein product |
| 04/21/1998 | US5741771 Plasminogen activator and thrombin-activatable plasminogen analogue |
| 04/21/1998 | US5741503 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/16/1998 | WO1998015576A1 Platelet secretory transport protein |
| 04/16/1998 | WO1998015547A1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
| 04/16/1998 | WO1998015521A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/16/1998 | WO1998015196A1 Compositions for postgastrectomic mineral supply |
| 04/16/1998 | CA2268172A1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
| 04/16/1998 | CA2267646A1 Platelet secretory transport protein |
| 04/16/1998 | CA2267129A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835265A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835116A1 Compounds and pharmaceutical compositions containing them |
| 04/15/1998 | EP0835113A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 04/15/1998 | EP0835109A1 Pyridinone-thrombin inhibitors |
| 04/15/1998 | EP0835104A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 04/15/1998 | CN1179107A Dried blood factor composition comprising trehalose |
| 04/14/1998 | US5739307 Cell growth factors |
| 04/14/1998 | US5739288 Fibrin sealant compositions |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739112 Anticoagulants |
| 04/14/1998 | US5739110 Protection of hemopoietic cells |
| 04/14/1998 | US5739012 Stable activator from genetically engineered cells |
| 04/14/1998 | US5738849 Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| 04/14/1998 | CA1339815C Modified factor vii/viia |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014476A1 Pharmaceutical compositions containing an mpl ligand |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/08/1998 | EP0833897A2 Prothrombin derivatives |
| 04/08/1998 | EP0833848A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
| 04/08/1998 | EP0833840A1 Hypoxia inducible factor-1 and method of use |
| 04/08/1998 | EP0833839A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833624A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/07/1998 | US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase |
| 04/07/1998 | US5736521 Administering amino acid compound |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 04/01/1998 | EP0832232A1 Kunitz type plasma kallikrein inhibitors |
| 04/01/1998 | EP0832228A1 Modified hemoglobin-like compounds and methods of purifying same |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832130A1 Separation of hemoglobin on hydroxyapatite using hplc |
| 04/01/1998 | EP0832129A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832102A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa |
| 04/01/1998 | EP0832077A1 Improved isoxazoline fibrinogen receptor antagonists |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0831888A1 Methods for increasing hematopoietic cells |
| 04/01/1998 | EP0831887A1 Therapy using lymphotoxin and thrombopoietin |
| 04/01/1998 | EP0831877A1 Metabolic effects of certain glutathione analogs |
| 04/01/1998 | EP0831817A1 Antigen-processing cell-targeted conjugates |
| 04/01/1998 | EP0831805A1 Methods for controlling highly unsaturated fatty acid content in various tissues |
| 04/01/1998 | EP0831793A1 Protein particles for therapeutic and diagnostic use |
| 04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/01/1998 | EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
| 03/31/1998 | US5733927 Antitumor agents and immunology |
| 03/31/1998 | US5733894 Water soluble polysaccharide oncotic agent |
| 03/31/1998 | US5733874 Stable dry powders |